Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cancer drugs
Pharma
FDA approves Regeneron's Libtayo for adjuvant use in CSCC
The FDA has approved Libtayo as the first immunotherapy for adjuvant treatment of cutaneous squamous cell carcinoma.
Kevin Dunleavy
Oct 9, 2025 11:00am
AZ, Genentech, Merck top oncology HCP promotions: report
Aug 14, 2025 11:52am
CDMO Simtra buys land for upcoming injectables expansion in US
Jul 28, 2025 3:50pm
Ratio, Ionetix ink separate radiopharmaceutical isotope deals
Jun 23, 2025 11:08am
AZ, Merck duke it out to lead oncologists’ pharma perceptions
May 22, 2025 10:54am
FDA to host first oncology adcomm meeting under Makary
May 8, 2025 11:35am
